Chelsea Olsen, PhD
About Chelsea Olsen, PhD
Chelsea Olsen, PhD, is a Director of Medical Writing with extensive experience in the pharmaceutical and biotechnology sectors. She has held various leadership roles at companies such as Structure Therapeutics, Global Blood Therapeutics, and Omeros Corporation, contributing to antiviral research and regulatory writing.
Current Role at Structure Therapeutics
Chelsea Olsen serves as the Director of Medical Writing at Structure Therapeutics, a position she has held since 2023. In this role, she is responsible for overseeing medical writing activities, ensuring that all documentation meets regulatory standards and aligns with the company's objectives. Her expertise in medical writing contributes to the development of therapeutic solutions within the organization.
Previous Experience in Medical Writing
Prior to her current position, Chelsea Olsen worked at Global Blood Therapeutics as the Director of Medical Writing from 2021 to 2023. She also held the role of Director of Regulatory Medical Writing at Omeros Corporation from 2017 to 2021. In these positions, she was involved in creating and managing critical documentation required for regulatory submissions and clinical trials.
Background in Virology and Program Management
Chelsea Olsen has a background in virology and program management, having worked at Kineta, Inc. as Associate Director of Program Management & Virology from 2014 to 2015. She also served as Director of Alliance Management at Kineta for a brief period in 2015. Her experience in these roles provided her with a solid foundation in managing complex projects within the biopharmaceutical industry.
Educational Qualifications
Chelsea Olsen earned her PhD in Molecular and Cellular Biology from Oregon State University. She also holds a Bachelor of Science (B.S.) degree in Microbiology from the same institution. Her educational background equips her with a strong understanding of biological sciences, which supports her work in medical writing and research.
Career Progression at SIGA Technologies
Chelsea Olsen's career at SIGA Technologies spanned several roles from 2001 to 2014. She began as a Research Associate and progressed to Senior Scientist, then to Group Leader in Dengue Antiviral Research and Development, and later to Associate Director of Antiviral Research and Development. This trajectory highlights her extensive experience in antiviral research and development.